Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus. Issue 5 (4th May 2021)

• Record Type: Journal Article
• Authors: Taulaigo, Anna Viola; Moschetti, Liala; Ganhão, Sara; Gerardi, Maria-Chiara; Franceschini, Franco; Tincani, Angela; Andreoli, Laura
• Is Part Of: Expert opinion on drug safety. Volume 20:Issue 5(2021)
• Page Start: 523
• Page End: 536
• Publication Date: 2021-05-04
• Subjects: Lupus erythematosus -- systemic -- pregnancy -- high-risk -- immunosuppressive agents -- biological therapy -- child of impaired parents -- preconception care; Drugs -- Side effects -- Periodicals; Drugs -- Toxicology -- Periodicals; Chemotherapy -- Periodicals; 615.704
• DOI: 10.1080/14740338.2021.1893298
• Languages: English
• ISSNs: 1474-0338

Abstract

ABSTRACT: Introduction : Systemic lupus erythematosus (SLE) mainly affects young females during childbearing age; therefore, reproductive issues are of major interest. Areas covered : Pregnancy planning is crucial to adjust the treatment toward drugs that are safe throughout pregnancy and breastfeeding. The evidence about drug safety is limited to post-marketing surveillance, registries, case series, and case reports, as pregnant patients are excluded from randomized clinical trials. The aim of this review is to report the safety considerations when treating pregnant SLE patients. Regarding maternal side effects of drugs, we focused on metabolic, infectious, and hemorrhagic complications. Fetal safety was analyzed looking at drugs teratogenicity, their possible effects on immune system, and on the long-term neuropsychological development of children. Expert opinion : The management of pregnancy in SLE has changed when knowledge about the safety of drugs has become available. Keeping SLE disease activity under control before, during and after pregnancy is of fundamental importance to ensure the best possible outcomes for mother and child. All these issues must be discussed with the patient and her family during preconception counseling. International efforts in terms of pregnancy registries and reproductive health guidelines help physicians improve their communication with SLE patients.